1
|
Mirkhani N, Christiansen MG, Gwisai T, Menghini S, Schuerle S. Spatially selective delivery of living magnetic microrobots through torque-focusing. Nat Commun 2024; 15:2160. [PMID: 38461256 PMCID: PMC10924878 DOI: 10.1038/s41467-024-46407-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 02/26/2024] [Indexed: 03/11/2024] Open
Abstract
Rotating magnetic fields enable biomedical microrobots to overcome physiological barriers and promote extravasation and accumulation in tumors. Nevertheless, targeting deeply situated tumors requires suppression of off-target actuation in healthy tissue. Here, we investigate a control strategy for applying spatially selective torque density to microrobots by combining rotating fields with magnetostatic selection fields. Taking magnetotactic bacteria as diffuse torque-based actuators, we numerically model off-target torque suppression, indicating the feasibility of centimeter to millimeter resolution for human applications. We study focal torque application in vitro, observing off-target suppression of actuation-dependent effects such as colonization of bacteria in tumor spheroids. We then design and construct a mouse-scale torque-focusing apparatus capable of maneuvering the focal point. Applying this system to a mouse tumor model increased accumulation of intravenously injected bacteria within tumors receiving focused actuation compared to non-actuated or globally actuated groups. This control scheme combines the advantages of torque-based actuation with spatial targeting.
Collapse
Affiliation(s)
- Nima Mirkhani
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Michael G Christiansen
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Tinotenda Gwisai
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Stefano Menghini
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Simone Schuerle
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092, Zurich, Switzerland.
| |
Collapse
|
2
|
Asgeirsson DO, Mehta A, Scheeder A, Li F, Wang X, Christiansen MG, Hesse N, Ward R, De Micheli AJ, Ildiz ES, Menghini S, Aceto N, Schuerle S. Magnetically controlled cyclic microscale deformation of in vitro cancer invasion models. Biomater Sci 2023; 11:7541-7555. [PMID: 37855703 DOI: 10.1039/d3bm00583f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2023]
Abstract
Mechanical cues play an important role in the metastatic cascade of cancer. Three-dimensional (3D) tissue matrices with tunable stiffness have been extensively used as model systems of the tumor microenvironment for physiologically relevant studies. Tumor-associated cells actively deform these matrices, providing mechanical cues to other cancer cells residing in the tissue. Mimicking such dynamic deformation in the surrounding tumor matrix may help clarify the effect of local strain on cancer cell invasion. Remotely controlled microscale magnetic actuation of such 3D in vitro systems is a promising approach, offering a non-invasive means for in situ interrogation. Here, we investigate the influence of cyclic deformation on tumor spheroids embedded in matrices, continuously exerted for days by cell-sized anisotropic magnetic probes, referred to as μRods. Particle velocimetry analysis revealed the spatial extent of matrix deformation produced in response to a magnetic field, which was found to be on the order of 200 μm, resembling strain fields reported to originate from contracting cells. Intracellular calcium influx was observed in response to cyclic actuation, as well as an influence on cancer cell invasion from 3D spheroids, as compared to unactuated controls. Furthermore, RNA sequencing revealed subtle upregulation of certain genes associated with migration and stress, such as induced through mechanical deformation, for spheroids exposed to actuation vs. controls. Localized actuation at one side of a tumor spheroid tended to result in anisotropic invasion toward the μRods causing the deformation. In summary, our approach offers a strategy to test and control the influence of non-invasive micromechanical cues on cancer cell invasion and metastasis.
Collapse
Affiliation(s)
- Daphne O Asgeirsson
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Avni Mehta
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Anna Scheeder
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
- Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge CB3 0AS, U.K
| | - Fan Li
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Xiang Wang
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Michael G Christiansen
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Nicolas Hesse
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Rachel Ward
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Andrea J De Micheli
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
- Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich 8032, Switzerland
| | - Ece Su Ildiz
- Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland
| | - Stefano Menghini
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| | - Nicola Aceto
- Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, 8093 Zurich, Switzerland
| | - Simone Schuerle
- Department of Health Sciences and Technology, Responsive Biomedical Systems Laboratory, ETH Zurich, 8093 Zurich, Switzerland.
| |
Collapse
|
3
|
Christiansen MG, Stöcklin LR, Forbrigger C, Venkatesh SA, Schuerle S. Inductive sensing of magnetic microrobots under actuation by rotating magnetic fields. PNAS Nexus 2023; 2:pgad297. [PMID: 37746329 PMCID: PMC10516638 DOI: 10.1093/pnasnexus/pgad297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Revised: 08/16/2023] [Accepted: 08/31/2023] [Indexed: 09/26/2023]
Abstract
The engineering space for magnetically manipulated biomedical microrobots is rapidly expanding. This includes synthetic, bioinspired, and biohybrid designs, some of which may eventually assume clinical roles aiding drug delivery or performing other therapeutic functions. Actuating these microrobots with rotating magnetic fields (RMFs) and the magnetic torques they exert offers the advantages of efficient mechanical energy transfer and scalable instrumentation. Nevertheless, closed-loop control still requires a complementary noninvasive imaging modality to reveal position and trajectory, such as ultrasound or X-rays, increasing complexity and posing a barrier to use. Here, we investigate the possibility of combining actuation and sensing via inductive detection of model microrobots under field magnitudes ranging from 100 s of microtesla to 10 s of millitesla rotating at 1 to 100 Hz. A prototype apparatus accomplishes this using adjustment mechanisms for both phase and amplitude to finely balance sense and compensation coils, suppressing the background signal of the driving RMF by 90 dB. Rather than relying on frequency decomposition to analyze signals, we show that, for rotational actuation, phase decomposition is more appropriate. We demonstrate inductive detection of a micromagnet placed in two distinct viscous environments using RMFs with fixed and time-varying frequencies. Finally, we show how magnetostatic selection fields can spatially isolate inductive signals from a micromagnet actuated by an RMF, with the resolution set by the relative magnitude of the selection field and the RMF. The concepts developed here lay a foundation for future closed-loop control schemes for magnetic microrobots based on simultaneous inductive sensing and actuation.
Collapse
Affiliation(s)
| | - Lucien R Stöcklin
- Department of Health Sciences and Technology, ETH Zurich, Zurich 8092, Switzerland
- Department of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland
| | - Cameron Forbrigger
- Department of Health Sciences and Technology, ETH Zurich, Zurich 8092, Switzerland
| | - Shashaank Abhinav Venkatesh
- Department of Health Sciences and Technology, ETH Zurich, Zurich 8092, Switzerland
- Department of Biomedical Engineering, National University of Singapore, Singapore 117575, Singapore
| | - Simone Schuerle
- Department of Health Sciences and Technology, ETH Zurich, Zurich 8092, Switzerland
| |
Collapse
|
4
|
Menghini S, Vizovisek M, Enders J, Schuerle S. Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells. Cancer Metab 2023; 11:12. [PMID: 37559137 PMCID: PMC10410830 DOI: 10.1186/s40170-023-00313-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 07/24/2023] [Indexed: 08/11/2023] Open
Abstract
The use of bacteria in cancer immunotherapy has the potential to bypass many shortcomings of conventional treatments. The ability of anaerobic bacteria to preferentially accumulate and replicate in hypoxic regions of solid tumors, as a consequence of bacterial metabolic needs, is particularly advantageous and key to boosting their immunostimulatory therapeutic actions in situ. While several of these bacterial traits are well-studied, little is known about their competition for nutrients and its effect on cancer cells which could serve as another potent and innate antineoplastic action. Here, we explored the consequences of the iron-scavenging abilities of a particular species of bacteria, Magnetospirillum magneticum, which has been studied as a potential new class of bacteria for magnetically targeted bacterial cancer therapy. We investigated their influence in hypoxic regions of solid tumors by studying the consequential metabolic effects exerted on cancer cells. To do so, we established an in vitro co-culture system consisting of the bacterial strain AMB-1 incubated under hypoxic conditions with human breast cancer cells MDA-MB-231. We first quantified the number of viable cells after incubation with magnetotactic bacteria demonstrating a lower rate of cellular proliferation that correlated with increasing bacteria-to-cancer cells ratio. Further experiments showed increasing populations of apoptotic cells when cancer cells were incubated with AMB-1 over a period of 24 h. Analysis of the metabolic effects induced by bacteria suggest an increase in the activation of executioner caspases as well as changes in levels of apoptosis-related proteins. Finally, the level of several human apoptosis-related proteins was investigated, confirming a bacteria-dependent triggering of apoptotic pathways in breast cancer cells. Overall, our findings support that magnetotactic bacteria could act as self-replicating iron-chelating agents and indicate that they interfere with proliferation and lead to increased apoptosis of cancer cells. This bacterial feature could serve as an additional antineoplastic mechanism to reinforce current bacterial cancer therapies.
Collapse
Affiliation(s)
- Stefano Menghini
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Matej Vizovisek
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Jonathas Enders
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, CH-8092, Zurich, Switzerland
| | - Simone Schuerle
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, CH-8092, Zurich, Switzerland.
| |
Collapse
|
5
|
Gwisai T, Mirkhani N, Christiansen MG, Nguyen TT, Ling V, Schuerle S. Magnetic torque–driven living microrobots for increased tumor infiltration. Sci Robot 2022; 7:eabo0665. [DOI: 10.1126/scirobotics.abo0665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Biohybrid bacteria–based microrobots are increasingly recognized as promising externally controllable vehicles for targeted cancer therapy. Magnetic fields in particular have been used as a safe means to transfer energy and direct their motion. Thus far, the magnetic control strategies used in this context rely on poorly scalable magnetic field gradients, require active position feedback, or are ill-suited to diffuse distributions within the body. Here, we present a magnetic torque–driven control scheme for enhanced transport through biological barriers that complements the innate taxis toward tumor cores exhibited by a range of bacteria, shown for
Magnetospirillum magneticum
as a magnetically responsive model organism. This hybrid control strategy is readily scalable, independent of position feedback, and applicable to bacterial microrobots dispersed by the circulatory system. We observed a fourfold increase in translocation of magnetically responsive bacteria across a model of the vascular endothelium and found that the primary mechanism driving increased transport is torque-driven surface exploration at the cell interface. Using spheroids as a three-dimensional tumor model, fluorescently labeled bacteria colonized their core regions with up to 21-fold higher signal in samples exposed to rotating magnetic fields. In addition to enhanced transport, we demonstrated that our control scheme offers further advantages, including the possibility for closed-loop optimization based on inductive detection, as well as spatially selective actuation to reduce off-target effects. Last, after systemic intravenous injection in mice, we showed significantly increased bacterial tumor accumulation, supporting the feasibility of deploying this control scheme clinically for magnetically responsive biohybrid microrobots.
Collapse
Affiliation(s)
- T. Gwisai
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zürich, 8092 Zürich, Switzerland
| | - N. Mirkhani
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zürich, 8092 Zürich, Switzerland
| | - M. G. Christiansen
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zürich, 8092 Zürich, Switzerland
| | - T. T. Nguyen
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zürich, 8092 Zürich, Switzerland
| | - V. Ling
- Takeda Pharmaceuticals, 40 Landsdowne St., Cambridge, MA 02139, USA
| | - S. Schuerle
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zürich, 8092 Zürich, Switzerland
| |
Collapse
|
6
|
Furer LA, Abad ÁD, Manser P, Hannig Y, Schuerle S, Fortunato G, Buerki-Thurnherr T. Novel electrospun chitosan/PEO membranes for more predictive nanoparticle transport studies at biological barriers. Nanoscale 2022; 14:12136-12152. [PMID: 35968642 DOI: 10.1039/d2nr01742c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
The design of safe and effective nanoparticles (NPs) for commercial and medical applications requires a profound understanding of NP translocation and effects at biological barriers. To gain mechanistic insights, physiologically relevant and accurate human in vitro biobarrier models are indispensable. However, current transfer models largely rely on artificial porous polymer membranes for the cultivation of cells, which do not provide a close mimic of the natural basal membrane and intrinsically provide limited permeability for NPs. In this study, electrospinning is exploited to develop thin chitosan/polyethylene oxide (PEO) membranes with a high porosity and nanofibrous morphology for more predictive NP transfer studies. The nanofiber membranes allow the cultivation of a tight and functional placental monolayer (BeWo trophoblasts). Translocation studies with differently sized molecules and NPs (Na-fluorescein; 40 kDa FITC-Dextran; 25 nm PMMA; 70, 180 and 520 nm polystyrene NPs) across empty and cell containing membranes reveal a considerably enhanced permeability compared to commercial microporous membranes. Importantly, the transfer data of NPs is highly similar to data from ex vivo perfusion studies of intact human placental tissue. Therefore, the newly developed membranes may decisively contribute to establish physiologically relevant in vitro biobarrier transfer models with superior permeability for a wide range of molecules and particles.
Collapse
Affiliation(s)
- Lea A Furer
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
- ETH Zürich, Responsive Biomedical Systems Lab, 8093 Zürich, Switzerland
| | - Ángela Díaz Abad
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| | - Pius Manser
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| | - Yvette Hannig
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| | - Simone Schuerle
- ETH Zürich, Responsive Biomedical Systems Lab, 8093 Zürich, Switzerland
| | - Giuseppino Fortunato
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Biomimetic Membranes and Textiles, 9014 St. Gallen, Switzerland
| | - Tina Buerki-Thurnherr
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland.
| |
Collapse
|
7
|
Christiansen MG, Schuerle S. Multi-channel control of fruit fly behaviour. Nat Mater 2022; 21:840-842. [PMID: 35761061 DOI: 10.1038/s41563-022-01305-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Affiliation(s)
- Michael G Christiansen
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, Zurich, Switzerland.
| | - Simone Schuerle
- Department of Health Sciences and Technology, Institute for Translational Medicine, ETH Zurich, Zurich, Switzerland
| |
Collapse
|
8
|
Halvachizadeh S, Klingebiel FKL, Pfeifer R, Gosteli M, Schuerle S, Cinelli P, Zelle BA, Pape HC. The local soft tissue status and the prediction of local complications following fractures of the ankle region. Injury 2022; 53:1789-1795. [PMID: 35382943 DOI: 10.1016/j.injury.2022.03.037] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Revised: 02/10/2022] [Accepted: 03/22/2022] [Indexed: 02/02/2023]
Abstract
INTRODUCTION Well-known risk factors (RF) for soft tissue complications following surgical treatment of fracture of the ankle region include diabetes, smoking, and the local soft tissue status. A weighted analysis might provide a risk profile that guides the surgical treatment strategy. The aim of this meta-analysis was to provide a risk profile for soft tissue complications following closed fractures of the ankle region. METHODS This review provides a meta-analysis of studies that investigate potential risk factors for complications in fractures of the ankle region. INCLUSION CRITERIA Original articles that were published between 2000 and 2020 in English or German language that calculated odds ratios (OR) of RF for soft tissue complications. Further, this study only includes articles that investigated fractures of the ankle region including pilon fracture, calcaneal fractures, and fractures of the malleoli. This study excluded articles that provide exploratory analyses, narrative reviews, and case reports. RF were stratified as patient specific systemic RF (PSS), patient specific local RF (PSL), and non-patient specific RF (NPS). PSS RF includes comorbidities, American society of anaesthesiology (ASA), requirement of medication, additional injuries, and smoking or substance abuse. PSL RF includes soft tissue status, wounds, and associated complications. NPS RF includes duration of surgery, staged procedure, or time to definitive surgery. Random effect (RE) models were utilized to summarize the effect measure (OR) for each group or specific RF. RESULTS Out of 1352 unique articles, 34 were included for quantitative analyses. Out of 370 complications, the most commonly assessed RF were comorbidities (34.6%). Local soft tissue status accounted for 7.5% of all complications. The overall rate for complication was 10.9% (standard deviation, SD 8.7%). PSS RF had an OR of 1.04 (95%CI 1.01 to 1.06, p = 0.006), PSL an OR of 1.79 (95% 1.28 to 2.49, p = 0.0006), and NPS RF an OR of 1.01 (95%CI 0.97 to 1.05, p = 0.595). Additional injuries did not predict complications (OR 1.23, 95%CI 0.44 to 3.45, p = 0.516). The most predictive RF were open fracture (OR 3.47, 95%CI 1.64 to 7.34, p < 0.001), followed by local tissue damage (OR 3.05, 95%CI 1.23 to 40.92, p = 0.04), and diabetes (OR 2.3, 95%CI 1.1 to 4.79, p = 0.26). CONCLUSION Among all RFs for regional soft tissue complications, the most predictive is the local soft tissue status, while additional injuries or NPS RF were less predictive. The soft tissue damage can be quantified and outweighs the cofactors described in previous publications. The soft tissue status appears to have a more important role in the decision making of the treatment strategy when compared with comorbidities such as diabetes.
Collapse
Affiliation(s)
- Sascha Halvachizadeh
- Department of Trauma, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland.
| | - Felix Karl Ludwig Klingebiel
- Department of Trauma, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland
| | - Roman Pfeifer
- Department of Trauma, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland
| | - Martina Gosteli
- Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland
| | - Simone Schuerle
- Institute for translational medicine, Department of Health Science & Technology, ETH Zurich, Rämistrasse 101, Zürich 8092, Switzerland
| | - Paolo Cinelli
- Department of Trauma, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland
| | - Boris A Zelle
- Department of Orthopaedics, UT Health San Antonio, San Antonio, Texas TX 78229, United States
| | - Hans-Christoph Pape
- Department of Trauma, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Harald Tscherne laboratory for orthopaedic and trauma research, University of Zurich, Sternwartstrasse 14, Zurich 8091, Switzerland
| |
Collapse
|
9
|
Dubey D, Christiansen MG, Vizovisek M, Gebhardt S, Feike J, Schuerle S. Engineering Responsive Ultrasound Contrast Agents Through Crosslinked Networks on Lipid-Shelled Microbubbles. Small 2022; 18:e2107143. [PMID: 35064638 DOI: 10.1002/smll.202107143] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2021] [Revised: 12/16/2021] [Indexed: 06/14/2023]
Abstract
Ultrasound imaging with contrast agents, especially with lipid-shelled microbubbles, has become a vital tool in clinical diagnostics. Efforts to adapt these agents for molecular imaging have typically focused on targeted binding. More recently, crosslinking the lipid shell to alter its mechanical properties, followed by decrosslinking upon exposure to a stimulus, has been shown as a promising approach for imaging soluble molecular targets. Nevertheless, a systematic study of the influence of crosslinker concentration and structure on the mechanical properties of microbubbles has not been undertaken. An improved understanding of the role of these parameters is necessary to more effectively design contrast agents that detect proteases, an informative class of soluble disease markers. Here, the influence of crosslinker parameters on the acoustic properties of microbubbles, developing a model of crosslinker network formation on microbubble shells that explains the experimental observations, are studied. By incorporating cleavable elements that respond to UV light or proteolysis, kinetically resolved acoustic detection of these stimuli and the relevance of crosslinker design are demonstrated. The framework established in this study can be readily adapted to other protease-cleavable units and provides a basis for the future development of responsive ultrasound contrast agents for molecular imaging of proteolytic activity.
Collapse
Affiliation(s)
- Dragana Dubey
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| | - Michael G Christiansen
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| | - Matej Vizovisek
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| | - Samuel Gebhardt
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| | - Jasmin Feike
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| | - Simone Schuerle
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Zurich, CH-8092, Switzerland
| |
Collapse
|
10
|
Asgeirsson DO, Christiansen MG, Valentin T, Somm L, Mirkhani N, Nami AH, Hosseini V, Schuerle S. 3D magnetically controlled spatiotemporal probing and actuation of collagen networks from a single cell perspective. Lab Chip 2021; 21:3850-3862. [PMID: 34505607 PMCID: PMC8507888 DOI: 10.1039/d1lc00657f] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Accepted: 08/28/2021] [Indexed: 05/15/2023]
Abstract
Cells continuously sense and react to mechanical cues from their surrounding matrix, which consists of a fibrous network of biopolymers that influences their fate and behavior. Several powerful methods employing magnetic control have been developed to assess the micromechanical properties within extracellular matrix (ECM) models hosting cells. However, many of these are limited to in-plane sensing and actuation, which does not allow the matrix to be probed within its full 3D context. Moreover, little attention has been given to factors specific to the model ECM systems that can profoundly influence the cells contained there. Here we present methods to spatiotemporally probe and manipulate extracellular matrix networks at the scale relevant to cells using magnetic microprobes (μRods). Our techniques leverage 3D magnetic field generation, physical modeling, and image analysis to examine and apply mechanical stimuli to fibrous collagen matrices. We determined shear moduli ranging between hundreds of Pa to tens of kPa and modeled the effects of proximity to rigid surfaces and local fiber densification. We analyzed the spatial extent and dynamics of matrix deformation produced in response to magnetic torques on the order of 10 pNm, deflecting fibers over an area spanning tens of micrometers. Finally, we demonstrate 3D actuation and pose extraction of fluorescently labelled μRods.
Collapse
Affiliation(s)
- Daphne O Asgeirsson
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| | - Michael G Christiansen
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| | - Thomas Valentin
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| | - Luca Somm
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| | - Nima Mirkhani
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| | - Amin Hosseini Nami
- Department of Biotechnology, College of Science, University of Tehran, Tehran 1417614411, Iran
| | - Vahid Hosseini
- Department of Bioengineering, University of California, Los Angeles, CA 90095, USA
- Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA
| | - Simone Schuerle
- Responsive Biomedical Systems Laboratory, Department of Health Science and Technology, ETH Zurich, 8093 Zurich, Switzerland.
| |
Collapse
|
11
|
Delamarche E, Temiz Y, Lovchik RD, Christiansen MG, Schuerle S. Capillary Microfluidics for Monitoring Medication Adherence. Angew Chem Int Ed Engl 2021. [DOI: 10.1002/ange.202101316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
| | - Yuksel Temiz
- IBM Research Europe Saeumerstrasse 4 Rueschlikon Switzerland
| | | | - Michael G. Christiansen
- Institute for Translational Medicine Department of Health Sciences and Technology ETH Zurich Vladimir-Prelog-Weg 1–5/10 8092 Zurich Switzerland
| | - Simone Schuerle
- Institute for Translational Medicine Department of Health Sciences and Technology ETH Zurich Vladimir-Prelog-Weg 1–5/10 8092 Zurich Switzerland
| |
Collapse
|
12
|
Delamarche E, Temiz Y, Lovchik RD, Christiansen MG, Schuerle S. Capillary Microfluidics for Monitoring Medication Adherence. Angew Chem Int Ed Engl 2021; 60:17784-17796. [PMID: 33710725 DOI: 10.1002/anie.202101316] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Revised: 03/08/2021] [Indexed: 02/06/2023]
Abstract
Medication adherence is a medical and societal issue worldwide, with approximately half of patients failing to adhere to prescribed treatments. The goal of this Minireview is to examine how recent work on microfluidics for point-of-care diagnostics may be used to enhance adherence to medication. It specifically focuses on capillary microfluidics since these devices are self-powered, easy to use, and well established for diagnostics and drug monitoring. Considering that an improvement in medication adherence can have a much larger effect than the development of new medical treatments, it is long overdue for the research communities working in chemistry, biology, pharmacology, and material sciences to consider developing technologies to enhance medication adherence. For these reasons, this Minireview is not meant to be exhaustive but rather to provide a quick starting point for researchers interested in joining this complex but intriguing and exciting field of research.
Collapse
Affiliation(s)
| | - Yuksel Temiz
- IBM Research Europe, Saeumerstrasse 4, Rueschlikon, Switzerland
| | | | - Michael G Christiansen
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8092, Zurich, Switzerland
| | - Simone Schuerle
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8092, Zurich, Switzerland
| |
Collapse
|
13
|
Vizovisek M, Ristanovic D, Menghini S, Christiansen MG, Schuerle S. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy. Int J Mol Sci 2021; 22:ijms22052514. [PMID: 33802262 PMCID: PMC7958950 DOI: 10.3390/ijms22052514] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 02/24/2021] [Accepted: 02/25/2021] [Indexed: 02/06/2023] Open
Abstract
In recent decades, dysregulation of proteases and atypical proteolysis have become increasingly recognized as important hallmarks of cancer, driving community-wide efforts to explore the proteolytic landscape of oncologic disease. With more than 100 proteases currently associated with different aspects of cancer development and progression, there is a clear impetus to harness their potential in the context of oncology. Advances in the protease field have yielded technologies enabling sensitive protease detection in various settings, paving the way towards diagnostic profiling of disease-related protease activity patterns. Methods including activity-based probes and substrates, antibodies, and various nanosystems that generate reporter signals, i.e., for PET or MRI, after interaction with the target protease have shown potential for clinical translation. Nevertheless, these technologies are costly, not easily multiplexed, and require advanced imaging technologies. While the current clinical applications of protease-responsive technologies in oncologic settings are still limited, emerging technologies and protease sensors are poised to enable comprehensive exploration of the tumor proteolytic landscape as a diagnostic and therapeutic frontier. This review aims to give an overview of the most relevant classes of proteases as indicators for tumor diagnosis, current approaches to detect and monitor their activity in vivo, and associated therapeutic applications.
Collapse
|
14
|
Menghini S, Ho PS, Gwisai T, Schuerle S. Magnetospirillum magneticum as a Living Iron Chelator Induces TfR1 Upregulation and Decreases Cell Viability in Cancer Cells. Int J Mol Sci 2021; 22:ijms22020498. [PMID: 33419059 PMCID: PMC7825404 DOI: 10.3390/ijms22020498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2020] [Revised: 12/23/2020] [Accepted: 01/04/2021] [Indexed: 11/16/2022] Open
Abstract
Interest has grown in harnessing biological agents for cancer treatment as dynamic vectors with enhanced tumor targeting. While bacterial traits such as proliferation in tumors, modulation of an immune response, and local secretion of toxins have been well studied, less is known about bacteria as competitors for nutrients. Here, we investigated the use of a bacterial strain as a living iron chelator, competing for this nutrient vital to tumor growth and progression. We established an in vitro co-culture system consisting of the magnetotactic strain Magnetospirillum magneticum AMB-1 incubated under hypoxic conditions with human melanoma cells. Siderophore production by 108 AMB-1/mL in human transferrin (Tf)-supplemented media was quantified and found to be equivalent to a concentration of 3.78 µM ± 0.117 µM deferoxamine (DFO), a potent drug used in iron chelation therapy. Our experiments revealed an increased expression of transferrin receptor 1 (TfR1) and a significant decrease of cancer cell viability, indicating the bacteria’s ability to alter iron homeostasis in human melanoma cells. Our results show the potential of a bacterial strain acting as a self-replicating iron-chelating agent, which could serve as an additional mechanism reinforcing current bacterial cancer therapies.
Collapse
|
15
|
Dheman K, Mayer P, Magno M, Schuerle S. Wireless, Artefact Aware Impedance Sensor Node for Continuous Bio-Impedance Monitoring. IEEE Trans Biomed Circuits Syst 2020; 14:1122-1134. [PMID: 32877339 DOI: 10.1109/tbcas.2020.3021186] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Body bio-impedance is a unique parameter to monitor changes in body composition non-invasively. Continuous measurement of bio-impedance can track changes in body fluid content and cell mass and has widespread applications for physiological monitoring. State-of-the-art implementation of bio-impedance sensor devices is still limited for continuous use, in part, due to artefacts arising at the skin-electrode (SE) interface. Artefacts at the SE interface may arise due to various factors such as motion, applied pressure on the electrode surface, changes in ambient conditions or gradual drying of electrodes. This paper presents a novel bio-impedance sensor node that includes an artefact aware method for bio-impedance measurement. The sensor node enables autonomous and continuous measurement of bio-impedance and SE contact impedance at ten frequencies between 10 kHz to 100 kHz to detect artefacts at the SE interface. Experimental evaluation with SE contact impedance models using passive 2R1C electronic circuits and also with non-invasive in vivo measurements of SE contact impedance demonstrated high accuracy (with maximum error less than 1.5%) and precision of 0.6 Ω. The ability to detect artefacts caused by motion, vertically applied pressure and skin temperature changes was analysed in proof of concept experiments. Low power sensor node design achieved with 50mW in active mode and only 143 μW in sleep mode estimated a battery life of 90 days with a 250 mAh battery and duty-cycling impedance measurements every 60 seconds. Our method for artefact aware bio-impedance sensing is a step towards autonomous and unobtrusive continuous bio-impedance measurement for health monitoring at-home or in clinical environments.
Collapse
|
16
|
Hosseini V, Mallone A, Mirkhani N, Noir J, Salek M, Pasqualini FS, Schuerle S, Khademhosseini A, Hoerstrup SP, Vogel V. A Pulsatile Flow System to Engineer Aneurysm and Atherosclerosis Mimetic Extracellular Matrix. Adv Sci (Weinh) 2020; 7:2000173. [PMID: 32596117 PMCID: PMC7312268 DOI: 10.1002/advs.202000173] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Indexed: 06/11/2023]
Abstract
Alterations of blood flow patterns strongly correlate with arterial wall diseases such as atherosclerosis and aneurysm. Here, a simple, pumpless, close-loop, easy-to-replicate, and miniaturized flow device is introduced to concurrently expose 3D engineered vascular smooth muscle tissues to high-velocity pulsatile flow versus low-velocity disturbed flow conditions. Two flow regimes are distinguished, one that promotes elastin and impairs collagen I assembly, while the other impairs elastin and promotes collagen assembly. This latter extracellular matrix (ECM) composition shares characteristics with aneurysmal or atherosclerotic tissue phenotypes, thus recapitulating crucial hallmarks of flow-induced tissue morphogenesis in vessel walls. It is shown that the mRNA levels of ECM of collagens and elastin are not affected by the differential flow conditions. Instead, the differential gene expression of matrix metalloproteinase (MMP) and their inhibitors (TIMPs) is flow-dependent, and thus drives the alterations in ECM composition. In further support, treatment with doxycycline, an MMP inhibitor and a clinically used drug to treat vascular diseases, halts the effect of low-velocity flow on the ECM remodeling. This illustrates how the platform can be exploited for drug efficacy studies by providing crucial mechanistic insights into how different therapeutic interventions may affect tissue growth and ECM assembly.
Collapse
Affiliation(s)
- Vahid Hosseini
- Laboratory of Applied MechanobiologyInstitute of Translational MedicineDepartment of Health Sciences and TechnologyETH ZurichZurich8093Switzerland
- Present address:
Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Anna Mallone
- Institute for Regenerative Medicine (IREM)University of Zurich and Wyss Translational Center ZurichZurich8952Switzerland
| | - Nima Mirkhani
- Responsive Biomedical Systems LabInstitute of Translational MedicineDepartment of Health Sciences and TechnologyETH ZurichZurich8093Switzerland
| | - Jerome Noir
- Institute of GeophysicsDepartment of Earth SciencesETH ZurichZurich8092Switzerland
| | - Mehdi Salek
- Department of Mechanical EngineeringMassachusetts Institute of TechnologyBostonMA02139USA
| | - Francesco Silvio Pasqualini
- Institute for Regenerative Medicine (IREM)University of Zurich and Wyss Translational Center ZurichZurich8952Switzerland
- Synthetic Physiology LaboratoryDepartment of Civil Engineering and ArchitectureUniversity of PaviaPavia27100Italy
| | - Simone Schuerle
- Responsive Biomedical Systems LabInstitute of Translational MedicineDepartment of Health Sciences and TechnologyETH ZurichZurich8093Switzerland
| | - Ali Khademhosseini
- Department of BioengineeringUniversity of California‐Los AngelesLos AngelesCA90095USA
| | - Simon P. Hoerstrup
- Institute for Regenerative Medicine (IREM)University of Zurich and Wyss Translational Center ZurichZurich8952Switzerland
| | - Viola Vogel
- Laboratory of Applied MechanobiologyInstitute of Translational MedicineDepartment of Health Sciences and TechnologyETH ZurichZurich8093Switzerland
| |
Collapse
|
17
|
Schuerle S, Furubayashi M, Soleimany AP, Gwisai T, Huang W, Voigt C, Bhatia SN. Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging. ACS Synth Biol 2020; 9:392-401. [PMID: 31922737 DOI: 10.1021/acssynbio.9b00416] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Tumor-selective contrast agents have the potential to aid in the diagnosis and treatment of cancer using noninvasive imaging modalities such as magnetic resonance imaging (MRI). Such contrast agents can consist of magnetic nanoparticles incorporating functionalities that respond to cues specific to tumor environments. Genetically engineering magnetotactic bacteria to display peptides has been investigated as a means to produce contrast agents that combine the robust image contrast effects of magnetosomes with the transgenic-targeting peptides displayed on their surface. This work reports the first use of magnetic nanoparticles that display genetically encoded pH low insertion peptide (pHLIP), a long peptide intended to enhance MRI contrast by targeting the extracellular acidity associated with the tumors. To demonstrate the modularity of this versatile platform to incorporate diverse targeting ligands by genetic engineering, we also incorporated the cyclic αv integrin-binding peptide iRGD into separate magnetosomes. Specifically, we investigate their potential for enhanced binding and tumor imaging both in vitro and in vivo. Our experiments indicate that these tailored magnetosomes retain their magnetic properties, making them well suited as T2 contrast agents, while exhibiting an increased binding compared to the binding in wild-type magnetosomes.
Collapse
Affiliation(s)
- Simone Schuerle
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092 Zurich, Switzerland
| | - Maiko Furubayashi
- Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Sapporo 062-8517, Japan
| | - Ava P. Soleimany
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Harvard Graduate Program in Biophysics, Harvard University, Boston, Massachusetts 02115, United States
- Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| | - Tinotenda Gwisai
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092 Zurich, Switzerland
| | - Wei Huang
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| | - Christopher Voigt
- Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| | - Sangeeta N. Bhatia
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Harvard-MIT Division of Health Sciences and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
- Marble Center for Cancer Nanomedicine, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
18
|
Hausmann MK, Hauser A, Siqueira G, Libanori R, Vehusheia SL, Schuerle S, Zimmermann T, Studart AR. Cellulose-Based Microparticles for Magnetically Controlled Optical Modulation and Sensing. Small 2020; 16:e1904251. [PMID: 31805220 DOI: 10.1002/smll.201904251] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 10/08/2019] [Indexed: 06/10/2023]
Abstract
Responsive materials with birefringent optical properties have been exploited for the manipulation of light in several modern electronic devices. While electrical fields are often utilized to achieve optical modulation, magnetic stimuli may offer an enticing complementary approach for controlling and manipulating light remotely. Here, the synthesis and characterization of magnetically responsive birefringent microparticles with unusual magneto-optical properties are reported. These functional microparticles are prepared via a microfluidic emulsification process, in which water-based droplets are generated in a flow-focusing device and stretched into anisotropic shapes before conversion into particles via photopolymerization. Birefringence properties are achieved by aligning cellulose nanocrystals within the microparticles during droplet stretching, whereas magnetic responsiveness results from the addition of superparamagnetic nanoparticles to the initial droplet template. When suspended in a fluid, the microparticles can be controllably manipulated via an external magnetic field to result in unique magneto-optical coupling effects. Using a remotely actuated magnetic field coupled to a polarized optical microscope, these microparticles can be employed to convert magnetic into optical signals or to estimate the viscosity of the suspending fluid through magnetically driven microrheology.
Collapse
Affiliation(s)
- Michael K Hausmann
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Cellulose & Wood Materials Laboratory, 8600, Dübendorf, Switzerland
- Complex Materials, Department of Materials, ETH Zurich, 8093, Zurich, Switzerland
| | - Alina Hauser
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Cellulose & Wood Materials Laboratory, 8600, Dübendorf, Switzerland
- Complex Materials, Department of Materials, ETH Zurich, 8093, Zurich, Switzerland
| | - Gilberto Siqueira
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Cellulose & Wood Materials Laboratory, 8600, Dübendorf, Switzerland
| | - Rafael Libanori
- Complex Materials, Department of Materials, ETH Zurich, 8093, Zurich, Switzerland
| | - Signe Lin Vehusheia
- Complex Materials, Department of Materials, ETH Zurich, 8093, Zurich, Switzerland
| | - Simone Schuerle
- Institute for Translational Medicine, Department of Health Science and Technology, ETH Zurich, 8092, Zurich, Switzerland
| | - Tanja Zimmermann
- Empa, Swiss Federal Laboratories for Materials Science and Technology, Cellulose & Wood Materials Laboratory, 8600, Dübendorf, Switzerland
| | - André R Studart
- Complex Materials, Department of Materials, ETH Zurich, 8093, Zurich, Switzerland
| |
Collapse
|
19
|
Schuerle S, Soleimany AP, Yeh T, Anand GM, Häberli M, Fleming HE, Mirkhani N, Qiu F, Hauert S, Wang X, Nelson BJ, Bhatia SN. Synthetic and living micropropellers for convection-enhanced nanoparticle transport. Sci Adv 2019; 5:eaav4803. [PMID: 31032412 PMCID: PMC6486269 DOI: 10.1126/sciadv.aav4803] [Citation(s) in RCA: 73] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Accepted: 03/08/2019] [Indexed: 05/09/2023]
Abstract
Nanoparticles (NPs) have emerged as an advantageous drug delivery platform for the treatment of various ailments including cancer and cardiovascular and inflammatory diseases. However, their efficacy in shuttling materials to diseased tissue is hampered by a number of physiological barriers. One hurdle is transport out of the blood vessels, compounded by difficulties in subsequent penetration into the target tissue. Here, we report the use of two distinct micropropellers powered by rotating magnetic fields to increase diffusion-limited NP transport by enhancing local fluid convection. In the first approach, we used a single synthetic magnetic microrobot called an artificial bacterial flagellum (ABF), and in the second approach, we used swarms of magnetotactic bacteria (MTB) to create a directable "living ferrofluid" by exploiting ferrohydrodynamics. Both approaches enhance NP transport in a microfluidic model of blood extravasation and tissue penetration that consists of microchannels bordered by a collagen matrix.
Collapse
Affiliation(s)
- S. Schuerle
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092 Zurich, Switzerland
| | - A. P. Soleimany
- Harvard Graduate Program in Biophysics, Harvard University, Boston, MA 02115, USA
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
| | - T. Yeh
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
| | - G. M. Anand
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
| | - M. Häberli
- Institute of Robotics and Intelligent Systems, ETH Zurich, CH-8092 Zurich, Switzerland
| | - H. E. Fleming
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
| | - N. Mirkhani
- Institute for Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, CH-8092 Zurich, Switzerland
| | - F. Qiu
- Institute of Robotics and Intelligent Systems, ETH Zurich, CH-8092 Zurich, Switzerland
| | - S. Hauert
- Engineering Mathematics, University of Bristol, Bristol BS8 1UB, UK
| | - X. Wang
- Institute of Robotics and Intelligent Systems, ETH Zurich, CH-8092 Zurich, Switzerland
| | - B. J. Nelson
- Institute of Robotics and Intelligent Systems, ETH Zurich, CH-8092 Zurich, Switzerland
| | - S. N. Bhatia
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Marble Center for Cancer Nanomedicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02139, USA
- Howard Hughes Medical Institute, Cambridge, MA 02139, USA
- Wyss Institute for Biologically Inspired Engineering at Harvard, Boston, MA 02115, USA
- Corresponding author.
| |
Collapse
|
20
|
Schuerle S, Vizcarra IA, Moeller J, Sakar MS, Özkale B, Lindo AM, Mushtaq F, Schoen I, Pané S, Vogel V, Nelson BJ. Robotically controlled microprey to resolve initial attack modes preceding phagocytosis. Sci Robot 2017; 2:2/2/eaah6094. [DOI: 10.1126/scirobotics.aah6094] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2016] [Accepted: 12/08/2016] [Indexed: 12/30/2022]
|
21
|
Abstract
Targeted cancer therapies require a precise determination of the underlying biological processes driving tumorigenesis within the complex tumor microenvironment. Therefore, new diagnostic tools that capture the molecular activity at the disease site in vivo are needed to better understand tumor behavior and ultimately maximize therapeutic responses. Matrix metalloproteinases (MMPs) drive multiple aspects of tumorigenesis, and their activity can be monitored using engineered peptide substrates as protease-specific probes. To identify tumor specific activity profiles, local sampling of the tumor microenvironment is necessary, such as through remote control of probes, which are only activated at the tumor site. Alternating magnetic fields (AMFs) provide an attractive option to remotely apply local triggering signals because they penetrate deep into the body and are not likely to interfere with biological processes due to the weak magnetic properties of tissue. Here, we report the design and evaluation of a protease-activity nanosensor that can be remotely activated at the site of disease via an AMF at 515 kHz and 15 kA/m. Our nanosensor was composed of thermosensitive liposomes containing functionalized protease substrates that were unveiled at the target site by remotely triggered heat dissipation of coencapsulated magnetic nanoparticles (MNPs). This nanosensor was combined with a unique detection assay to quantify the amount of cleaved substrates in the urine. We applied this spatiotemporally controlled system to determine tumor protease activity in vivo and identified differences in substrate cleavage profiles between two mouse models of human colorectal cancer.
Collapse
Affiliation(s)
- Simone Schuerle
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139
| | - Jaideep S. Dudani
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139
| | - Michael G. Christiansen
- Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
| | - Polina Anikeeva
- Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Corresponding Authors: Address: Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76-453, Cambridge, MA 02139, USA. Phone: + 1 617 324 0610, ; Address: Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 8-425, Cambridge, MA 02139, USA. Phone: + 1 617-253-3301,
| | - Sangeeta N. Bhatia
- Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139
- Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139
- Marble Center for Cancer Nanomedicine, Massachusetts Institute of Technology, Cambridge, MA 02139
- Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02139
- Howard Hughes Medical Institute, Cambridge, MA 02139
- Corresponding Authors: Address: Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76-453, Cambridge, MA 02139, USA. Phone: + 1 617 324 0610, ; Address: Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 8-425, Cambridge, MA 02139, USA. Phone: + 1 617-253-3301,
| |
Collapse
|
22
|
Schuerle S, Pané S, Pellicer E, Sort J, Baró MD, Nelson BJ. Helical and tubular lipid microstructures that are electroless-coated with CoNiReP for wireless magnetic manipulation. Small 2012; 8:1498-1502. [PMID: 22411925 DOI: 10.1002/smll.201101821] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/02/2011] [Revised: 01/12/2012] [Indexed: 05/31/2023]
Abstract
Hybrid magnetic phospholipidic-based tubular and helical microagents are wirelessly manipulated by means of a 5-DOF electromagnetic system. Two different strategies are used to manipulate these nanostructures in simulated biologic capillaries. Tubules are pulled by applying magnetic field gradients and oriented by magnetic fields. Helices exhibit a cork-screw motion similar to the swimming strategy used by motile bacteria such as E. coli.
Collapse
Affiliation(s)
- Simone Schuerle
- Institute of Robotics and Intelligent Systems, ETH Zurich, Zurich, Switzerland
| | | | | | | | | | | |
Collapse
|